Molecular diagnostics primarily refers to a class of diagnostic test that analyzes nucleic acids or proteins at a molecular level. This class of diagnostics is identified as rapidly evolving and fastest growing segment of in-vitro diagnostics industry.
Albany, NY -- (SBWIRE) -- 04/20/2016 -- Molecular diagnostics is defined as a class of diagnostic tests which identifies genetic and molecular biomarkers of an individual patient. It is essentially an analysis of RNA and DNA at the molecular level. This class of diagnostics tests is considered as the most well established and lucrative market in the clinical applications segment. Traditionally, usage of molecular diagnostics was limited due to requirement of highly skilled professionals and high cost of tests. However, recent reduction in cost per sample analysis, labor costs, improvements in automation and introduction of advanced technologies have expanded the usage of molecular diagnostics tests. The growth of this market is expected to surge due to various factors such as rise in incidence of hospital acquired infections, increase in patient awareness along with growing elderly population. Additionally, outbreak of diseases such as H1N1, growing incidence of diseases such as HIV and hepatitis have augmented the growth of this market.
Read Complete Report @ http://www.mrrse.com/molecular-diagnostics-industry
The research report on molecular diagnostics provides detailed analysis of the global market and helps in understanding the driving forces responsible for its growth. The report discusses the molecular diagnostics market on the basis of different technologies and applications. The technology segment comprises polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization technique, microarray, next generation sequencing and others. The application segment is classified into infectious diseases, blood donor screening and genomics. The genomics segmented is further classified into genetic disorders testing, oncology testing, HLA testing and pharmacogenetic testing. The infectious diseases segment is subsegmented into virology and bacteriology. The virology section of the report deals with testing of following infections namely, HIV (Human immunodeficiency virus), HPV (Human papillomavirus), HCV (Hepatitis C virus) and others. The bacteriology segment of the report is further categorized into hospital acquired infections (HAI), CT/NG (Chlamydia trachomatis and Neisseria gonorrhoeae) and others. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments in terms of USD million using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.
Read Full Table of Content @ http://www.mrrse.com/molecular-diagnostics-industry/toc
The molecular diagnostics market has also been segmented geographically into four regions: North America, Europe, Asia Pacific and Rest of the World (RoW), and respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global molecular diagnostics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter's five forces analysis for the molecular diagnostics market that would help in determining the degree of competition in the market. The entire section of market overview plays an important role in understanding the market on a global level. Further, the report on molecular diagnostics also provides executive summary that that will help you understand the overall market size, growth rate of various segments, geographies and competitors present in the market in a very precise manner.
Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/1080
The molecular diagnostics market report also provides a highlight of the competitive landscape of the market wherein the market share analysis of the leading players in the market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the molecular diagnostics market such as Abbott Laboratories, Becton Dickinson & Company, Cepheid, Roche Diagnostics and others. Profiles of these players have been extensively analyzed on the basis of company overview, financial overview, business strategies, product portfolio and recent developments.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.
More Research Reports Database @ http://www.mrrse.com/